Journey Medical Corp. Files Q1 2025 10-Q
Ticker: DERM · Form: 10-Q · Filed: May 15, 2025 · CIK: 1867066
Sentiment: neutral
Topics: 10-Q, financials, pharmaceuticals
TL;DR
JMEK Q1 2025 10-Q filed. Financials updated.
AI Summary
Journey Medical Corp. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including common stock, retained earnings, and additional paid-in capital. The company's principal business address is in Scottsdale, Arizona.
Why It Matters
This filing provides investors with an update on Journey Medical Corp.'s financial health and performance for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- Q1 2025 — Reporting Period (Financials for the first quarter of 2025 are detailed.)
- March 31, 2025 — Balance Sheet Date (Key financial figures are as of this date.)
Key Players & Entities
- Journey Medical Corp. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- Scottsdale, AZ (location) — Company business address
- 0001867066 (company) — Central Index Key for Journey Medical Corp.
FAQ
What is the primary business of Journey Medical Corp.?
Journey Medical Corp. is in the Pharmaceutical Preparations industry, SIC code 2834.
What is the fiscal year end for Journey Medical Corp.?
The fiscal year end for Journey Medical Corp. is December 31.
What is the SEC file number for Journey Medical Corp.?
The SEC file number for Journey Medical Corp. is 001-41063.
When was this 10-Q filing submitted?
This 10-Q filing was submitted on May 15, 2025.
What are some of the key financial statement components mentioned for March 31, 2025?
The filing mentions Common Stock, Retained Earnings, and Additional Paid-In Capital as of March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Journey Medical Corp (DERM).